Clinically tested formulations with demonstrated effectiveness in cardiovascular protection and heart health management.
Effective blood pressure regulation with minimal side effects and improved patient adherence to treatment.
Manufactured under strict WHO-GMP guidelines ensuring highest quality standards and cardiovascular safety profiles.
Comprehensive cardiovascular solutions tailored for different patient needs and treatment protocols
Our Kplol range employs cutting-edge pharmaceutical technology including Angiotensin Receptor Blockers (ARBs) to deliver optimal cardiovascular outcomes with enhanced end-organ protection, superior patient compliance, and comprehensive safety.
Selective beta-1 receptor blockade for optimal heart rate control and cardioprotective effects.
Advanced formulation for sustained blood pressure reduction with minimal side effects.
Long-term cardiovascular protection with improved patient outcomes and quality of life.
Selective angiotensin II receptor blockade providing superior end-organ protection and renoprotective effects.
Up to 40% reduction in cardiovascular events with ARB-based combination therapy and significant improvement in blood pressure control with enhanced end-organ protection
High patient compliance and satisfaction rates in cardiovascular studies
Significant reduction in major cardiovascular events with ARB-based combinations
Superior end-organ protection with ARB therapy, especially for diabetic patients
Round-the-clock cardiovascular protection with XL formulations
Excellent safety and tolerability in long-term cardiovascular studies
Kplol Tablet is a prescription cardiovascular medication manufactured by Kreios Pharma. It contains Metoprolol Succinate (a selective beta-1 blocker) combined with Telmisartan (an Angiotensin Receptor Blocker), providing a dual-action approach to managing hypertension, angina, and heart failure. The Kplol range is available in multiple strengths to suit different patient needs.
Kplol Tablet should be taken as prescribed by a qualified healthcare professional. The usual recommended dosages are:
Note: Do not alter the dose without medical advice. Always consult your physician before starting or stopping Kplol.
Kplol is generally well tolerated. Some patients may experience:
Most side effects are mild and resolve on their own. Contact your doctor if symptoms persist or worsen.
Kreios Pharma offers a comprehensive range of pharmaceutical products across multiple therapeutic areas:
For partnership opportunities or bulk enquiries, visit our Business Partner page or contact us directly.
